(Q33499922)

27 July 2017

1 reference

title

Interferon therapy and autoimmunity (English)

1 reference

27 July 2017

Fritzsch J

1

1 reference

PubMed ID

9244832

27 July 2017

Krug J

series ordinal

2

1 reference

PubMed ID

9244832

27 July 2017

Heberling HJ

series ordinal

3

1 reference

27 July 2017

1 May 1997

1 reference

27 July 2017

1 reference

27 July 2017

92

1 reference

27 July 2017

265-272

1 reference

27 July 2017

5

1 reference

Immune thrombocytopenia associated with carcinoma

27 July 2017

1 reference

https://api.crossref.org/works/10.1007%2FBF03045081

Interferon in chronic polyarthritis. Positive effect in clinical evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03045081

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03045081

Mechanisms of action of interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03045081

Immune thrombocytopenia following alpha-interferon therapy in patients with cancer

21 January 2018

1 reference

12 December 2020

Induction of hyperthyroidism by interferon-alpha-2b

1 reference

12 December 2020

Antiphospholipid syndrome associated with immunotherapy for patients with melanoma

1 reference

12 December 2020

Interferon therapy for agnogenic myeloid metaplasia complicated by immune hemolytic anemia

1 reference

12 December 2020

Transient thyrotoxicosis and persistent hypothyroidism due to acute autoimmune thyroiditis after interleukin-2 and interferon-alpha therapy for metastatic carcinoma: a case report

1 reference

12 December 2020

Two Cases of Hypothyroidism Associated with Alpha-Interferon Therapy

1 reference

12 December 2020

Psoriasis and alpha-interferon

1 reference

12 December 2020

Autoantibodies and response to alpha-interferon in patients with chronic viral hepatitis

1 reference

12 December 2020

Autoimmune hepatitis type 1 revealed during treatment with interferon

1 reference

12 December 2020

Exacerbation of multiple sclerosis after the administration of recombinant human interferon alfa

1 reference

12 December 2020

Thyrotropin receptor antibodies following treatment with recombinant alpha-interferon in patients with hepatitis

1 reference

12 December 2020

Autoimmune Phenomena in Patients with Malignant Carcinoid Tumors During Interferon-α Treatment

1 reference

12 December 2020

A case of pemphigus foliaceus after interferon alpha-2a therapy

1 reference

12 December 2020

Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis

1 reference

12 December 2020

Long term therapy with recombinant interferon alpha 2 b in patients with chronic hepatitis C: effects on thyroid function and autoantibodies

1 reference

12 December 2020

Autoantibody occurrence in hairy cell leukemia

1 reference

12 December 2020

Interferon or C virus-induced autoimmune chronic hepatitis? Report of personal observations and review of the literature

1 reference

12 December 2020

Exacerbation of psoriasis after treatment with alpha-interferon

1 reference

12 December 2020

Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis

1 reference

12 December 2020

Selective inhibition of the generation of T suppressor cells of contact sensitivity in vitro by interferon

1 reference

12 December 2020

Recombinant alpha-interferons, thyroid irradiation and thyroid disease

1 reference

12 December 2020

[What is assured in therapy of chronic viral hepatitis?]

1 reference

12 December 2020

A case of arthropathy and hypothyroidism during recombinant alpha-interferon therapy

1 reference

12 December 2020

Antierythrocyte autoantibody formation after therapy with interleukin-2 and gamma-interferon

1 reference

12 December 2020

Autoantibodies during alpha-interferon therapy for chronic hepatitis B

1 reference

12 December 2020

Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy

1 reference

12 December 2020

Bleeding in immune thrombocytopenic purpura after alpha-interferon

1 reference

12 December 2020

Treatment of malignant carcinoid tumors with recombinant interferon alfa-2b: development of neutralizing interferon antibodies and possible loss of antitumor activity

1 reference

12 December 2020

Acute exacerbation of liver disease during interferon alfa therapy for chronic hepatitis C

1 reference

12 December 2020

Acquired factor VIII inhibitor associated with chronic interferon-alpha therapy.

1 reference

12 December 2020

Induction of systemic lupus erythematosus by interferon-gamma in a patient with rheumatoid arthritis

1 reference

12 December 2020

Induction of insulin antibodies and insulin allergy under alpha-interferon treatment of renal cell carcinoma in a patient with insulin-treated diabetes mellitus--a case report

1 reference

12 December 2020

Hemolytic anemia in a cancer patient treated with recombinant interferon-gamma.

1 reference

12 December 2020

3 cases of polyarthritis treated with recombinant alfa interferon

1 reference

12 December 2020

Hypoparathyroidism during alpha-INF therapy in a patient with multiple myeloma

1 reference

12 December 2020

Development of thyroid autoimmunity after administration of recombinant human interferon-alpha 2b for chronic viral hepatitis

1 reference

12 December 2020

Development of transient thyroid disease and reaction during treatment of chronic hepatitis C with interferon

1 reference

12 December 2020

Recombinant interferon-alpha, -beta, and -gamma enhance the proliferative response of human B cells

1 reference

12 December 2020

Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa

1 reference

12 December 2020

High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy

1 reference

12 December 2020

Exacerbation of psoriasis during alpha-interferon therapy

1 reference

12 December 2020

Systemic lupus erythematosus in a child receiving long-term interferon therapy

1 reference

12 December 2020

Alpha-interferon-induced nodular rheumatoid arthritis in renal cell carcinoma

1 reference

12 December 2020

Hypothyroidism followed by interferon-alpha as adjuvant therapy of renal cell carcinoma: a case report

1 reference

12 December 2020

Bullous eruption with circulating pemphigus-like antibodies following interferon-alpha therapy

1 reference

12 December 2020

[Autoimmune biological anomalies in 35 patients with chronic viral hepatitis C treated over 6 months with interferon and followed-up over a year]

1 reference

12 December 2020

Immune thrombocytopenia and interferon alfa

1 reference

12 December 2020

Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha

1 reference

12 December 2020

Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells

1 reference

12 December 2020

Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disorders

1 reference

12 December 2020

Hazards of interferon therapy for HBV-seronegative chronic hepatitis.

1 reference

12 December 2020

Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C

1 reference

12 December 2020

Occurrence of IDDM during interferon therapy for chronic viral hepatitis

1 reference

12 December 2020

Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia

1 reference

12 December 2020

Autoantibodies to epithelial cells in patients on long-term therapy with leucocyte-derived interferon-alpha (IFN-α)

1 reference

12 December 2020

Mono-arthritis in a chronic hepatitis B patient after alpha-interferon treatment

1 reference

12 December 2020

Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon

1 reference

12 December 2020

Hypothyroidism and goitre during interleukin-2 therapy without LAK cells

1 reference

12 December 2020

Interferons and systemic lupus erythematosus

1 reference

12 December 2020

Effects of Interferon-γ Therapy on Thyroid Function, T-Lymphocyte Subpopulations and Induction of Autoantibodies

1 reference

12 December 2020

Psoriasis with articular involvement induced by interferon alfa

1 reference

12 December 2020

Interferon-induced chronic active hepatitis?

1 reference

12 December 2020

The risk factor for development of thyroid disease during interferon-alpha therapy for chronic hepatitis C

1 reference

12 December 2020

Recombinant gamma interferon and autoimmune thyroid disease

1 reference

12 December 2020

Interferon alfa therapy in severe unresponsive subacute cutaneous lupus erythematosus.

1 reference

12 December 2020

Induction of autoimmune phenomena in patients with chronic hepatitis B treated with gamma-interferon

1 reference

12 December 2020

Induction of experimental thyroiditis in mice by recombinant interferon gamma administration

1 reference

12 December 2020

Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity

1 reference

12 December 2020

An autoimmune aetiology for hypothyroidism following interferon therapy for breast cancer

1 reference

12 December 2020

35-year-old patient with chronic myelogenous leukemia developing systemic lupus erythematosus after alpha-interferon therapy

1 reference

12 December 2020

Autoimmune chronic hepatitis exacerbated by alpha-interferon

1 reference

12 December 2020

Sustained hypothyroidism induced by recombinant alpha interferon in patients with chronic hepatitis C.

1 reference

12 December 2020

Immune thrombocytopenia after alpha-interferon therapy in a patient with chronic hepatitis C

1 reference

12 December 2020

Possible induction of systemic lupus erythematosus by interferon-α treatment in a patient with a malignant carcinoid tumour

1 reference

12 December 2020

Effect of interferon on psoriasis

1 reference

12 December 2020

Arthritis in patients with psoriasis treated with gamma-interferon

1 reference

12 December 2020

Autoimmune haemolytic anaemia associated with interferon alfa-2a in a patient with mycosis fungoides

1 reference

12 December 2020

Hemolytic anemia secondary to interferon treatment for chronic B hepatitis

1 reference

12 December 2020

Alpha-interferon and immune hemolytic anemia

1 reference

12 December 2020

Auto-immune thrombocytopenia related to interferon therapy

1 reference

12 December 2020

Thyroid Function Abnormalities Associated with the Chronic Outpatient Administration of Recombinant Interleukin-2 and Recombinant Interferon-Alpha

1 reference

12 December 2020

Psoriasis induced by interferon-α

1 reference

12 December 2020

Interferon-alpha induced autoimmune hepatitis in a patient with Philadelphia chromosome-positive chronic myeloid leukemia with cytogenetically normal T lymphocytes

1 reference

12 December 2020

Cytokine therapeutics: lessons from interferon alpha

1 reference

12 December 2020

Thyroid dysfunction and liver injury following alpha-interferon treatment of chronic viral hepatitis

1 reference

12 December 2020

Clinical toxicity of the interferons.

1 reference

12 December 2020

Autoantibody occurrence in hairy-cell leukemia during prolonged interferon treatment

1 reference

12 December 2020

Induction of antinuclear antibodies in patients with rheumatoid arthritis receiving treatment with human recombinant interferon gamma

1 reference

12 December 2020

Hypothyroidism and arthritis during interferon therapy

1 reference

12 December 2020

Autoimmunity during alpha-interferon therapy for chronic hepatitis C

1 reference

12 December 2020

Lymphokines in autoimmunity--a critical review

1 reference

12 December 2020

Does interferon-beta therapy induce thyroid autoimmune phenomena?

1 reference

12 December 2020

[Paraneoplastic syndromes]

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03045081

1 reference

27 July 2017

1 reference

PubMed ID

9244832